APP and Alzheimer disease: In our study, we found that although there was no significant difference in GLUT5 expression between APP/PS1 mice and WT mice, the ratio of GLUT5-positive microglia was increased in the DG of APP/PS1 mice, in parallel with the microglial increase, suggesting increased glucose demand of microglia in AD pathology.